Trial intelligence / Profile preview

Ondansetron for prevention of hypotension after spinal anesthesia in cesarean delivery

IRCT20130812014333N99Phase 2Completed

Sponsor
Kermanshah University of Medical Sciences
Start
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of ondansetron in hypotension induced by spinal anesthesia (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: blood pressure, nausea and vomiting and 2 more. Started Aug 2018; status: completed.

02

Drugs

ondansetron
03

Conditions

hypotension induced by spinal anesthesia

Beyond the preview

Go deeper on IRCT20130812014333N99.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20130812014333N99.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call